The Top 10 Diagnostics Deals of 2021

The Top 10 Diagnostics Deals of 2021

by Glenn S. Demby | Dec 3, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report, Must read

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

by Glenn S. Demby | Nov 4, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

by Glenn S. Demby | Oct 5, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

Illumina Makes Audacious Move by Completing Grail Acquisition Without Regulatory Approval

Illumina Makes Audacious Move by Completing Grail Acquisition Without Regulatory Approval

by Glenn S. Demby | Sep 13, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

PerkinElmer Acquires BioLegend While FTC Warns Against Non-Approved Mergers

Biden Orders Feds to Target Health Care Consolidation but Deals Continue

by Glenn S. Demby | Aug 26, 2021 | Articles, Deals-lir, Essential, Laboratory Industry Report, Must read

...

Subscribe to View

Start a Free Trial for immediate access to this article

Already a member? Log in here

« Older Entries

Sign up for our free weekly Lab & Pathology Insider email newsletter

Email*

Country*